Voyager Therapeutics, Inc. VYGR
1.61 USD 0.00 (+0.00%)
Regular-session close
1.60 -0.01 -0.62%
Pre-market · Nov 20, 4:00 AM ET
1.56 Day range 1.68
1.48 52-week range 5.48
- YTD
- -59.03%
- 1 year
- -60.64%
Benzinga news
benzinga.com Voyager Therapeutics Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $4.014M Miss $6.350M Estimate Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 14.89 percent increase over losses of…
benzinga.com Voyager Therapeutics Appoints Robin Swartz As President, Effective October 20, And Is Expected To Become CEO In Q1 2027 Swartz is expected to succeed Alfred W. Sandrock, Jr., M.D., Ph.D., as Chief Executive Officer (CEO) in Q1 2027, following the receipt of initial acute safety data from a clinical trial of Voyager’s…
